{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:15:19Z","timestamp":1778991319853,"version":"3.51.4"},"reference-count":94,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T00:00:00Z","timestamp":1343174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:p>Denosumab is a fully human monoclonal antibody against RANK ligand (RANKL), an essential cytokine for the formation, function, and survival of osteoclasts. The role of excessive RANKL as a contributor to conditions characterized by bone loss or bone destruction has been well studied. With its novel mechanism of action, denosumab offers a significant advance in the treatment of postmenopausal osteoporosis; bone loss associated with hormone ablation therapy in women with breast cancer and men with prostate cancer; and the prevention of skeletal\u2010related events in patients with bone metastases from solid tumors by offering clinical benefit to these patients in need.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2012.06674.x","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T18:20:25Z","timestamp":1343240425000},"page":"29-40","source":"Crossref","is-referenced-by-count":36,"title":["The development of denosumab for the treatment of diseases of bone loss and cancer\u2010induced bone destruction"],"prefix":"10.1111","volume":"1263","author":[{"given":"Carsten","family":"Goessl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Dougall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Kostenuik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly Brenza","family":"Zoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Dansey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel B.","family":"Wagman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.18.2412"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3540"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64556-7"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81569-X"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3597"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.9.1260"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/16852"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-008-9133-6"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.266"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.11.7497"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2003.09.001"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1326-y"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.4.490"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0014"},{"key":"e_1_2_10_17_2","volume-title":"WHO Technical Report","author":"Kanis J.A.","year":"2007"},{"key":"e_1_2_10_18_2","volume-title":"Clinician's Guide to Prevention and Treatment of Osteoporosis","year":"2009"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08657-9"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-6-201003160-00008"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-006-0011-8"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2006.07.003"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.12.002"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0322-8"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.11.024"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.20.2414"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.04.001"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.03.769"},{"key":"e_1_2_10_29_2","unstructured":"Prolia US prescribing information.2012. Amgen.http:\/\/pi.amgen.com\/united_states\/prolia\/prolia_pi.pdf"},{"key":"e_1_2_10_30_2","unstructured":"Prolia EU Prescribing Information.2012.http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_\u2010_Product_Information\/human\/001120\/WC500093526.pdf"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040305"},{"key":"e_1_2_10_32_2","first-page":"1107","article-title":"Effects of denosumab on bone mineral density and biochemical markers of bone turnover over 8 years","volume":"63","author":"McClung M.R.","year":"2011","journal-title":"Arthritis Rheum."},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809493"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1472"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01124-X"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.984"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050814"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1479"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.0809010"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090716"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60320-0"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.81"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.03.423"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2814"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1502"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.448"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1755-2"},{"key":"e_1_2_10_48_2","unstructured":"Bone H.G.et al.2012. The effect of six years of denosumab treatment on new vertebral and nonvertebral fractures in postmenopausal women with osteoporosis: results from the FREEDOM extension trial. Presented at the 94th Annual Meeting of the Endocrine Society Houston Texas June 23\u201326 2012."},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.06.011"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.05.024"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1533500100"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr242"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.0923"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.405"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041943"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.50"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-384"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1595"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64561-2"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.3832"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809003"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61226-9"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0931"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.05.044"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0109"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2442"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030831"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2507"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20678"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.09.002"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/74999"},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-007-9127-1"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.03.001"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.9.7.11266"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09027"},{"key":"e_1_2_10_76_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0915148107"},{"key":"e_1_2_10_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09091"},{"key":"e_1_2_10_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09495"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09387"},{"key":"e_1_2_10_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09707"},{"key":"e_1_2_10_81_2","unstructured":"Xgeva US prescribing information.2012. Amgen Inc.http:\/\/pi.amgen.com\/united_states\/xgeva\/xgeva_pi.pdf"},{"key":"e_1_2_10_82_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.105"},{"key":"e_1_2_10_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.19.1458"},{"key":"e_1_2_10_84_2","unstructured":"Zometa US prescribing information.2010. Novartis.http:\/\/www.pharma.us.novartis.com\/product\/pi\/pdf\/Zometa.pdf"},{"key":"e_1_2_10_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.04.023"},{"key":"e_1_2_10_86_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.8604"},{"key":"e_1_2_10_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62344-6"},{"key":"e_1_2_10_88_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.3304"},{"key":"e_1_2_10_89_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7101"},{"key":"e_1_2_10_90_2","first-page":"viii380","article-title":"Comparison of denosumab versus zoledronic acid (ZA) for the treatment of bone metastases in advanced cancer patients: an integrated analysis of 3 pivotal trials","volume":"21","author":"Lipton A.","year":"2010","journal-title":"Ann. Oncol."},{"key":"e_1_2_10_91_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.9133"},{"key":"e_1_2_10_92_2","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active\u2010controlled phase III trials in cancer patients with bone metastases","author":"Saad F.","year":"2011","journal-title":"Ann. Oncol."},{"key":"e_1_2_10_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70010-3"},{"key":"e_1_2_10_94_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.10034"},{"key":"e_1_2_10_95_2","volume-title":"Denosumab for treatment of hypercalcemia of malignancy in patients with solid tumors or hematological malignancies refractory to IV bisphosphonates: a single\u2010arm multicenter study","author":"Hu M.I.","year":"2011"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2012.06674.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2012.06674.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T08:29:07Z","timestamp":1694939347000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2012.06674.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1111\/j.1749-6632.2012.06674.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06674.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}